Stephen Macfarlane

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Pain in Dementia: Prevalence and Association With Neuropsychiatric Behaviors

Mustafa Atee, Thomas Morris, Stephen Macfarlane et al. · Journal of Pain and Symptom Management · 2020 · 110 citations · Full text

Medicine, Geriatric Medicine, Neurology +16

Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease

Bárbara Rita Cardoso, Blaine R. Roberts, Charles B. Malpas et al. · Neurotherapeutics · 2018 · 109 citations · Full text

Medicine, Neurology, Neuroscience +12

The impact upon extra‐pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia

Craig Ritchie, E. Chiu, Susy Harrigan et al. · International Journal of Geriatric Psychiatry · 2003 · 87 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer’s Disease

Charles B. Malpas, Lucy Vivash, Sila Genc et al. · Journal of Alzheimer s Disease · 2016 · 75 citations

Life Sciences, Neurology, Neuroscience +17